4.7 Article

Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high- level CpG Island methylator phenotype and mismatch repair- deficiency

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions

Felipe De Sousa E Melo et al.

NATURE MEDICINE (2013)

Article Gastroenterology & Hepatology

Colorectal cancer: a tale of two sides or a continuum?

Mai Yamauchi et al.

Article Multidisciplinary Sciences

Comprehensive molecular characterization of human colon and rectal cancer

Donna M. Muzny et al.

NATURE (2012)

Article Medicine, Research & Experimental

V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a

Linda A. S. Carragher et al.

EMBO MOLECULAR MEDICINE (2010)

Article Gastroenterology & Hepatology

Role of the Serrated Pathway in Colorectal Cancer Pathogenesis

Barbara Leggett et al.

GASTROENTEROLOGY (2010)

Article Oncology

Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer

Yoshifumi Baba et al.

CLINICAL CANCER RESEARCH (2009)

Article Oncology

Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis

P. Minoo et al.

JOURNAL OF PATHOLOGY (2007)

Article Oncology

Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer

Wade S. Samowitz et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)

Article Pathology

CDX-2, a new marker for adenocarcinoma of gastrointestinal origin

MK Li et al.

ADVANCES IN ANATOMIC PATHOLOGY (2004)

Article Gastroenterology & Hepatology

Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands

M van Rijnsoever et al.

Article Oncology

The homeobox gene CDX2 in colorectal carcinoma:: a genetic analysis

S Sivagnanasundaram et al.

BRITISH JOURNAL OF CANCER (2001)